Takeda Pharmaceutical Company Limited (LON:0A87)

LON:0A87 Statistics

Total Valuation

LON:0A87 has a market cap or net worth of GBP 32.76 billion. The enterprise value is 55.14 billion.

Market Cap	32.76B
Enterprise Value	55.14B

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	Mar 31, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	46.86%
Float	1.53B

Valuation Ratios

The trailing PE ratio is 197.03.

PE Ratio	197.03
Forward PE	n/a
PS Ratio	1.48
PB Ratio	0.91
P/TBV Ratio	n/a
P/FCF Ratio	6.40
P/OCF Ratio	5.43
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.39, with an EV/FCF ratio of 10.78.

EV / Earnings	331.63
EV / Sales	2.52
EV / EBITDA	9.39
EV / EBIT	23.12
EV / FCF	10.78

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.73.

Current Ratio	1.37
Quick Ratio	0.65
Debt / Equity	0.73
Debt / EBITDA	4.37
Debt / FCF	5.10
Interest Coverage	2.30

Financial Efficiency

Return on equity (ROE) is 0.47% and return on invested capital (ROIC) is 2.44%.

Return on Equity (ROE)	0.47%
Return on Assets (ROA)	2.09%
Return on Invested Capital (ROIC)	2.44%
Return on Capital Employed (ROCE)	3.94%
Revenue Per Employee	467,901
Profits Per Employee	3,504
Employee Count	47,455
Asset Turnover	0.30
Inventory Turnover	1.24

Taxes

In the past 12 months, LON:0A87 has paid 324.87 million in taxes.

Income Tax	324.87M
Effective Tax Rate	66.00%

Stock Price Statistics

The stock price has increased by +3.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+3.78%
50-Day Moving Average	13.60
200-Day Moving Average	13.77
Relative Strength Index (RSI)	50.54
Average Volume (20 Days)	1,080

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0A87 had revenue of GBP 22.20 billion and earned 166.27 million in profits. Earnings per share was 0.10.

Revenue	22.20B
Gross Profit	14.39B
Operating Income	2.44B
Pretax Income	492.20M
Net Income	166.27M
EBITDA	5.72B
EBIT	2.44B
Earnings Per Share (EPS)	0.10

Balance Sheet

The company has 3.43 billion in cash and 26.10 billion in debt, giving a net cash position of -22.67 billion.

Cash & Cash Equivalents	3.43B
Total Debt	26.10B
Net Cash	-22.67B
Net Cash Per Share	n/a
Equity (Book Value)	35.85B
Book Value Per Share	22.69
Working Capital	3.93B

Cash Flow

In the last 12 months, operating cash flow was 6.03 billion and capital expenditures -914.36 million, giving a free cash flow of 5.12 billion.

Operating Cash Flow	6.03B
Capital Expenditures	-914.36M
Free Cash Flow	5.12B
FCF Per Share	n/a

Margins

Gross margin is 64.80%, with operating and profit margins of 11.01% and 0.75%.

Gross Margin	64.80%
Operating Margin	11.01%
Pretax Margin	2.22%
Profit Margin	0.75%
EBITDA Margin	25.77%
EBIT Margin	11.01%
FCF Margin	23.04%

Dividends & Yields

This stock pays an annual dividend of 0.44, which amounts to a dividend yield of 3.09%.

Dividend Per Share	0.44
Dividend Yield	3.09%
Dividend Growth (YoY)	2.01%
Years of Dividend Growth	n/a
Payout Ratio	935.06%
Buyback Yield	-0.65%
Shareholder Yield	2.45%
Earnings Yield	0.51%
FCF Yield	15.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0A87 has an Altman Z-Score of 1.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.14
Piotroski F-Score	6